WHO ICTRP trial
Clinical study of rimimazolam tosilate on postoperative cognitive dysfunction in…
ChiCTR2100046613 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100046613 |
|---|---|
| Public title | Clinical study of rimimazolam tosilate on postoperative cognitive dysfunction in patients undergoing knee surgery |
| Scientific title | Clinical study of rimimazolam tosilate on postoperative cognitive dysfunction in patients undergoing knee surgery |
| Primary sponsor | Affiliated Hospital of Zunyi Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | postoperative cognitive dysfunction |
| Interventions | experimental group 1:rimimazolam tosilate 0.1mg/kg;experimental group 2:rimimazolam tosilate 0.2mg/kg;experimental group 3:rimimazolam tosilate 0.3mg/kg;control group:???? 0.2mg |
| Registration date | May 23, 2021 |
| Target size | experimental group 1:30;experimental group 2:30;experimental group 3:30;control… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: